Physician profile
Stuart Deaderick
NPI 1922443183
$7,043.59
in general payments reported to CMS, 2019-2025
16 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,762 · 2020: $160 · 2021: $1,209 · 2022: $388 · 2023: $245 · 2024: $38.35 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $943 · Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $942.59 |
| Food and Beverage | $581.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $1,777.83 | 2019 | |
| Stryker Corporation | $1,540.97 | 2019-2025 | Augment Injectable, Spinejack, Optablate |
| Medtronic, INC. | $1,225.93 | 2021-2024 | Osteocool Rf Ablation System, Mvp, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $1,203.66 | 2019-2020 | |
| Boston Scientific Corporation | $494.54 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $214.78 | 2019-2025 | Trek, Powerport M.R.I. Implantable Port, Mission |
| Terumo Medical Corporation | $183.86 | 2020-2024 | Azur Cx Detachable |
| Angiodynamics, INC. | $113.74 | 2019 | |
| W. L. Gore & Associates, INC. | $87.27 | 2021 | |
| Ekos Corporation | $47.56 | 2019 | |
| Penumbra, INC. | $35.86 | 2020 | |
| Medtronic Vascular, INC. | $31.08 | 2020 | |
| Eisai INC. | $23.61 | 2019 | |
| Si-Bone, INC. | $21.92 | 2023 | |
| Siemens Medical Solutions USA, INC. | $21.01 | 2025 | Acuson Sequoia Diagnostic Ultrasound System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $19.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Deaderick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.